阿摩線上測驗
登入
首頁
>
研究所、轉學考(插大)◆臨床藥學及治療學
>
110年 - 110 國立臺灣大學_碩士班招生考試_臨床藥學研究所:臨床藥學及治療學#102126
> 申論題
題組內容
二、配合題:請將下列藥品相對應的法定適應症之代码,標明題號作客於試卷内之「非選擇題作答區」。答案可能不 只一個,可重視選擇,(10分)
9.teriparatide
相關申論題
10.topiramate
#429254
(一)請簡述哪些藥品(不含外用製劑)可作為慢性疼痛的輔助性治療,請說明其藥理類別,並各類至少列舉一藥品 學名。(10分)
#429255
(二)請說明加上輔助性治療藥品之目的,及不同種類藥品在選用上的考量。(10分)
#429256
(1) Translate the underlined sentences (marked with ①②③④⑤ in front of the sentences) into Chinese. (16 points)
#429257
(2) What were the percentages of volunteers diagnosed severe Covid-19 in each group? Please list your calculation. (2 points)
#429258
(3) What were the percentages of volunteers deceased due to Covid-19 in each group? Please list your calculation. (2 points)
#429259
(4) The mRNA-1273 vaccine demonstrates a novel mechanism of action. Provide I example of cach type of traditional vaccines, Iive-attenuated vaccines and inactivated vaccines, and their precautions or contraindications. (5 points)
#429260
(1) Translate the underlined sentences (marked with 0@ 8 in front of the sentences) into Chinese. (S points)
#429261
(2) Explain the rationale for metformin being the preferred initial pharmacologic agent for the treatment of type 2 diabetes (T2DM) in terms of cardiovascular comorbid conditions, hypoglycemia risk, impact on weight, cost and risk for side effects, etc. (3 points)
#429262
(3) List one SGLT2 inhibitor and one GLP-1 RA with demonstrated cardiovascular benefit recommended for T2DM patients who have established ASCVD or indicators of high risk, established kidney disease or heart failure. (4 points)
#429263
相關試卷
110年 - 110 國立臺灣大學_碩士班招生考試_臨床藥學研究所:臨床藥學及治療學#102126
110年 · #102126
阿摩線上測驗
登入
阿摩線上測驗
登入